SUSTAIN 340B Act proposes major changes for hospitals and pharmacies
A bipartisan working group in Congress released a preliminary legislative draft that attempts to resolve some of the most disputed aspects of the 340B Drug Pricing Program. One noteworthy provision in the legislation would curtail the 340B rebate model, which was finalized by the Health Resources and Services Administration on July 31 and is scheduled to begin Jan.…
HRSA sets 2027 launch for the 340B rebate model, announces requirements
The Health Resources and Services Administration (HRSA) followed through with plans to pilot a rebate model for the 340B Drug Pricing Program beginning Jan. 1, 2027. As described in a notice published July 31, HRSA previously scrapped plans for a 2026 pilot following litigation. In response to that legal challenge, the agency provided additional information…
Medicaid work requirement lawsuit targets CMS exemption rules
July 30 update A federal judge at the U.S. District Court for Massachusetts denied a request for a preliminary injunction of CMS regulations implementing the Medicaid work requirement. The plaintiffs specifically challenged how the regulations defined medically frail as a criterion for an exemption to the work requirement, plus how a specific short-term hardship exception…
Utilization review, HIPAA updates and more
Nick Hut talks with HFMA’s Kathy Stull about the Medicaid work requirement and 340B developments. Erika Grotto discusses utilization review with Kevin Coloton, CEO of HURC and HIPAA updates with Jon Bilotti, enterprise technology consultant at BCS365.
340B bill would levy various restrictions on participating hospitals
Legislative language overhauling the 340B Drug Pricing Program faces a long and uncertain path in Congress but would have significant implications if some of the provisions become law. A preliminary bill draft released by Sen. Bill Cassidy (R-La.) would tighten oversight of hospitals and contract pharmacies, increase transparency and require 340B discounts to be transferred…
Update: Litigation about the 340B program’s ‘patient’ definition could affect hospital savings
Note: This story is an update to prior coverage. Providers weighing in on potentially disruptive litigation involving the 340B Drug Pricing Program say a ruling in favor of the drug manufacturer would have substantial implications for the program. In a case brought by AbbVie Inc. against the federal government, the central question concerns the definition…
340B rebate model pilot advances as providers warn of added costs
The Health Resources and Services Administration (HRSA) continues to take steps toward implementing a rebate model for the 340B Drug Pricing Program. After soliciting comments on a planned model over a two-month period, HRSA sent an updated notice May 27 to the Office of Management and Budget (OMB) for a review that remains ongoing. That…
Annual Conference 2026, Day 2: With government retrenching, the impetus is on healthcare industry stakeholders to boost sustainability
Monday video recap: AC26 Day 2 Recap: Big Questions, Bold Conversations In this roundup: With government retrenching, the impetus is on healthcare industry stakeholders to bolster sustainability Insights from the ‘affordability czar’ Jordan reflects on HFMA’s history and what lies ahead Vitalic Health session looks at how technology can drive a better system Most health…
340B claims data requirements put hospital discounts under stress
June 18 update Eli Lilly has followed through with cutting off 340B discounts for certain hospitals that have yet to submit the required claims data (see the original story below), provider advocacy groups said Thursday. “As a result of Lilly’s decision to deny hospitals access to 340B pricing for the company’s products unless they submit…
Leveraging integrated workforce data is integral to transforming healthcare performance
With rising labor expenses, staffing challenges, and growing complexity in operations, leaders now look for innovative methods to maximize the benefits of workforce data and boost organizational performance. This white paper shares how to develop a workforce optimization cycle in your organization, along with insight into why it’s necessary and the risks of inaction.